Fig. 2From: Validation of a new prognostic model to predict short and medium-term survival in patients with liver cirrhosisKaplan-Meier estimates according to CreLiMAx risk score cut-off values. (patients were censored at time of transplantation or not liver-related death). The Breslow-Wilcoxon test was used to determine differences between survival curves: p = 0.223 (CreLiMAx risk score cut-off 0.9) for 3 months, p = 0.003 (CreLiMAx risk score cut-off 0.9) for 6 months and p = 0.002 (CreLiMAx risk score cut-off 0.9) for 12 months, respectivelyBack to article page